Anthropic CEO Dario Amodei on Monday laid out the startup’s vision for how AI could solve problems in healthcare and the life sciences, from speeding up drug approvals by streamlining clinical trial ...
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...
Friday, Aurora Therapeutics debuted with $16 million in seed capital from Menlo Ventures. Its goal: To develop the industry’s ...
He Jiankui spent three years in prison after creating gene-edited babies. Now back at work, he sees a greater opening for ...
The Global Agtech and Advanced Food Technologies Market Report 2026-2036 reveals promising growth opportunities in vertical farming, smart farming, and alternative proteins, driven by population ...
GlobalData on MSN
FDA increases manufacturing flexibility for cell and gene therapies
Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
A UK startup aiming to solve key challenges in life sciences through AI has unveiled the “world’s first AI models for ...
Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...
Baby KJ was the first to receive a bespoke gene-editing treatment. Personalized drugs for others could be approved within the ...
Aurora Therapeutics has emerged from stealth with $16 million in funding from Menlo Ventures to expand the potential of gene ...
A newly discovered genetic form of neonatal diabetes shows how a single gene defect shuts down insulin production in newborns ...
University of New Mexico researchers found that the immune enzyme OTULIN drives tau production, brain inflammation and aging.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback